Galmed Pharmaceuticals (GLMD) EBT (QoQ) (2013 - 2023)
Galmed Pharmaceuticals (GLMD) EBT (QoQ) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Galmed Pharmaceuticals | 2.39 Mn | -9.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 172.55% |
| Sep 30, 2022 | -147.11% |
| Mar 31, 2021 | 100.03% |
| Dec 31, 2020 | -200.08% |
| Sep 30, 2020 | 7,886.26% |
| Jun 30, 2020 | -2,100.00% |
| Mar 31, 2020 | -99.69% |
| Dec 31, 2019 | 758,836.36% |
| Sep 30, 2019 | 31.25% |
| Jun 30, 2019 | 55.56% |
| Mar 31, 2019 | -100.97% |
| Dec 31, 2018 | 319.23% |
| Sep 30, 2018 | 12,728.57% |
| Jun 30, 2018 | -124.14% |
| Mar 31, 2018 | -99.20% |
| Dec 31, 2017 | 30.10% |
| Sep 30, 2017 | 4.05% |
| Jun 30, 2017 | -15.24% |
| Mar 31, 2017 | -34.19% |
| Dec 31, 2016 | 29.49% |